SONIA
GATIUS CALDERO
CON
![Foto de SONIA](/img/nophoto.png)
![Foto de Centro de Investigación Biomédica en Red de Cáncer](/img/noimage_org.png)
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (10)
2024
-
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review
Cancers, Vol. 16, Núm. 1
2023
-
In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers
Advanced Science, Vol. 10, Núm. 32
-
Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness
Molecular Oncology, Vol. 17, Núm. 1, pp. 98-118
2022
-
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma
Molecular Oncology, Vol. 16, Núm. 11, pp. 2235-2259
-
Abdominal tumors in patients with neurofibromatosis type I: Genotype-phenotype relationships
European Journal of Medical Genetics, Vol. 65, Núm. 11
-
Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression
Oncogene, Vol. 41, Núm. 13, pp. 1835-1850
-
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer
Cancers, Vol. 14, Núm. 12
2019
-
Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis
Journal of Pathology, Vol. 247, Núm. 1, pp. 72-85
2017
-
Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias
Journal of Pathology, Vol. 242, Núm. 2, pp. 152-164
-
Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients
Oncotarget, Vol. 8, Núm. 65, pp. 109018-109026